GeneSilico
PrivateCompany Overview
GeneSilico operates in Healthcare & Life Sciences and is based in Austin, Texas. It was founded in 2023.
GeneSilico is a software provider company that develops an AI-powered precision oncology platform to unify genomics, pathology, and clinical research, empowering oncologists to deliver personalized care.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GeneSilico Comparables
Compare GeneSilico with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genomate Health | 84% | |
| CureMatch | 83% | |
| ArteraAI | 79% |
For institutional investors. Book with your work email.
GeneSilico Funding Rounds
Historical fundraising activity
GeneSilico Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GeneSilico's valuation, stock price, and market status.
Is GeneSilico a public or private company?
GeneSilico is a private company.
What is the current stock price of GeneSilico?
GeneSilico is a private company, so its shares have no public market price. Caplight tracks GeneSilico's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GeneSilico worth (valuation)?
Valuation information for GeneSilico is not publicly available.
Can I buy GeneSilico stock?
GeneSilico shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GeneSilico's last funding round?
Funding round information for GeneSilico is not publicly available.
Who are the main investors in GeneSilico?
Investor information for GeneSilico is not publicly disclosed.
Will GeneSilico IPO soon?
No public IPO plans have been announced for GeneSilico.
How can I track GeneSilico secondary market activity?
Caplight tracks bids, offers, and trades in GeneSilico's shares on secondary markets.